C07D 277/64
With only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Official title: with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
C07D277/64 (With only hydrocarbon or substituted hydrocarbon radicals attached in position 2) appears on 1,107 US grants and 1,162 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,107
- Published applications
- 1,162
- Assignees
- 662
- Inventors
- 3,960
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 8 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 5 | 0 |
| 1984 | 7 | 0 |
| 1985 | 14 | 0 |
| 1986 | 5 | 0 |
| 1987 | 9 | 0 |
| 1988 | 7 | 0 |
| 1989 | 12 | 0 |
| 1990 | 14 | 0 |
| 1991 | 12 | 0 |
| 1992 | 9 | 0 |
| 1993 | 16 | 0 |
| 1994 | 14 | 0 |
| 1995 | 17 | 0 |
| 1996 | 18 | 0 |
| 1997 | 24 | 0 |
| 1998 | 25 | 0 |
| 1999 | 12 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 3 |
| 2002 | 19 | 26 |
| 2003 | 26 | 35 |
| 2004 | 19 | 65 |
| 2005 | 28 | 47 |
| 2006 | 34 | 62 |
| 2007 | 26 | 47 |
| 2008 | 25 | 44 |
| 2009 | 28 | 58 |
| 2010 | 29 | 55 |
| 2011 | 35 | 38 |
| 2012 | 43 | 40 |
| 2013 | 34 | 38 |
| 2014 | 41 | 72 |
| 2015 | 54 | 62 |
| 2016 | 45 | 67 |
| 2017 | 57 | 50 |
| 2018 | 42 | 58 |
| 2019 | 41 | 38 |
| 2020 | 24 | 42 |
| 2021 | 31 | 37 |
| 2022 | 26 | 46 |
| 2023 | 25 | 49 |
| 2024 | 34 | 40 |
| 2025 | 23 | 31 |
| 2026 | 18 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Compound for organic electric element, organic electric element using same, and electronic device thereof15 Sep 2026US 12,735,407 B2Duk San Neolux Co., Ltd.
- Organic light emitting element15 Sep 2026US 12,740,317 B2LG Display Co., Ltd.
- Compound, polymerizable composition, polymer, holographic recording medium, optical material, and optical component25 Aug 2026US 12,717,227 B2Mitsubishi Chemical Corporation
- Nematicidal compounds, their composition and use thereof13 Aug 2026US 2026/0231945 A1
- Compounds, their composition and their use as nematicides13 Aug 2026US 2026/0234101 A1
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
- Phosphine ligands and their use in coupling reactions13 Aug 2026US 2026/0234175 A1BASF SE
- Amide compounds or salts thereof, bactericidal agents for agriculture and horticulture containing said compounds, and method of using same23 Jul 2026US 2026/0206763 A1Nihon Nohyaku Co., Ltd.
Most cited
By later US patents
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase226US 5,480,883 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1996
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase209US 5,409,930 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1995
- Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase198US 5,710,158 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1998
- Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions182US 4,740,519 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1988
- Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase171US 5,646,153 ARhone-Poulenc Rorer Pharmaceuticals Inc. · 1997